Improved prediction of immune checkpoint blockade efficacy across multiple cancer types.
Nat Biotechnol. 2022 Apr;40(4):499-506. doi: 10.1038/s41587-021-01070-8. Epub 2021 Nov 1.
Nat Biotechnol. 2022.
PMID: 34725502